| Dr Angela Beninga, DO, | |
|
2020 Peachtree Rd Ne, Atlanta, GA 30309 | |
| (404) 352-2020 | |
| Not Available |
| Full Name | Dr Angela Beninga |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 19 Years |
| Location | 2020 Peachtree Rd Ne, Atlanta, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386867356 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shepherd Center, Inc. | 1052301777 | 43 |
News Archive
A study led by Mayo Clinic shows for the first time that a drug appears to have a slowing effect - though limited - on the progression from mild cognitive impairment to Alzheimer's disease. The findings will be published online in the New England Journal of Medicine on April 14.
The human body is comprised of billions of cells. Yet it functions and grows as a single organism, because of trillions of interactions that help various cells recognize and respond to each other via different molecules on their surface or inside the cells. Now, a new study published in the journal Nature in April 2020 describes the first-ever interactome map, to help distinguish healthy interactions and disease-producing ones.
BioLife Solutions, Inc., a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, and HemaCare Corporation, a leading supplier of blood derived cells and components for research and clinical applications, today announced a strategic relationship wherein HemaCare will market BioLife's HypoThermosol and CryoStor biopreservation media products and HemaCare's blood derived cells to the research and clinical communities.
Carrageenan, is a polymer derived from red seaweed which helps to create a protective physical barrier in the nasal cavity and has proven to be an effective antiviral in the treatment of the common cold.
BioTime, Inc. (OTCBB:BTIM) announced today that it will organize a new subsidiary, BioTime Asia, Limited, for the purpose of clinically developing and marketing therapeutic stem cell products in the People's Republic of China, and marketing stem cell research products in China and other countries in Asia.
› Verified 1 days ago
| Entity Name | Shepherd Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043311715 PECOS PAC ID: 1052301777 Enrollment ID: O20040514000768 |
News Archive
A study led by Mayo Clinic shows for the first time that a drug appears to have a slowing effect - though limited - on the progression from mild cognitive impairment to Alzheimer's disease. The findings will be published online in the New England Journal of Medicine on April 14.
The human body is comprised of billions of cells. Yet it functions and grows as a single organism, because of trillions of interactions that help various cells recognize and respond to each other via different molecules on their surface or inside the cells. Now, a new study published in the journal Nature in April 2020 describes the first-ever interactome map, to help distinguish healthy interactions and disease-producing ones.
BioLife Solutions, Inc., a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, and HemaCare Corporation, a leading supplier of blood derived cells and components for research and clinical applications, today announced a strategic relationship wherein HemaCare will market BioLife's HypoThermosol and CryoStor biopreservation media products and HemaCare's blood derived cells to the research and clinical communities.
Carrageenan, is a polymer derived from red seaweed which helps to create a protective physical barrier in the nasal cavity and has proven to be an effective antiviral in the treatment of the common cold.
BioTime, Inc. (OTCBB:BTIM) announced today that it will organize a new subsidiary, BioTime Asia, Limited, for the purpose of clinically developing and marketing therapeutic stem cell products in the People's Republic of China, and marketing stem cell research products in China and other countries in Asia.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Angela Beninga, DO, 390 Highbrook Dr, Atlanta, GA 30342-2315 Ph: () - | Dr Angela Beninga, DO, 2020 Peachtree Rd Ne, Atlanta, GA 30309 Ph: (404) 352-2020 |
News Archive
A study led by Mayo Clinic shows for the first time that a drug appears to have a slowing effect - though limited - on the progression from mild cognitive impairment to Alzheimer's disease. The findings will be published online in the New England Journal of Medicine on April 14.
The human body is comprised of billions of cells. Yet it functions and grows as a single organism, because of trillions of interactions that help various cells recognize and respond to each other via different molecules on their surface or inside the cells. Now, a new study published in the journal Nature in April 2020 describes the first-ever interactome map, to help distinguish healthy interactions and disease-producing ones.
BioLife Solutions, Inc., a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, and HemaCare Corporation, a leading supplier of blood derived cells and components for research and clinical applications, today announced a strategic relationship wherein HemaCare will market BioLife's HypoThermosol and CryoStor biopreservation media products and HemaCare's blood derived cells to the research and clinical communities.
Carrageenan, is a polymer derived from red seaweed which helps to create a protective physical barrier in the nasal cavity and has proven to be an effective antiviral in the treatment of the common cold.
BioTime, Inc. (OTCBB:BTIM) announced today that it will organize a new subsidiary, BioTime Asia, Limited, for the purpose of clinically developing and marketing therapeutic stem cell products in the People's Republic of China, and marketing stem cell research products in China and other countries in Asia.
› Verified 1 days ago
Miss Ashley Johnson, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2020 Peachtree Rd Nw, Atlanta, GA 30309 Phone: 404-352-2020 | |
Di Cui, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 59 Executive Park S, #2000, Atlanta, GA 30329 Phone: 404-778-7138 | |
Joyce L Terrell, ATC Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: West End Well Werks, Llc, 1062 Ralph David Abernathy Blvd Sw, Atlanta, GA 30310 Phone: 678-471-4615 Fax: 404-921-9233 | |
Dr. Dale Christian Strasser, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1441 Clifton Rd Ne, Atlanta, GA 30322 Phone: 404-778-5770 Fax: 404-712-5668 | |
Anna Choo Elmers, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2020 Peachtree Rd Nw, Atlanta, GA 30309 Phone: 404-603-4279 Fax: 404-350-7381 | |
Dr. Thomas H Xu, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2001 Peachtree Rd Ne Ste 550, Atlanta, GA 30309 Phone: 404-299-3338 | |
Mikhail Zhukalin, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1648 Pierce Dr. Ne, Atlanta, GA 30307 Phone: 515-770-7556 |